New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
09:21 EDTEXASFDA says Exact Sciences colorectal cancer screening tool study met objectives
Exact Sciences' Deep-C study met the primary objectives with respect to both required sensitivity and specificity of the company's Cologuard test compared to colonoscopy, FDA staff wrote in briefing documents ahead of the March 27 meeting of the Molecular and Clinical Advisory Committee Panel. With respect to the secondary objectives, Cologuard sensitivity is higher than FIT for both CRC and AA, FDA staff noted. Cologuard is an in vitro diagnostic device designed to analyze patientsí stool for the presence of colorectal cancer. Reference Link
News For EXAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
09:01 EDTEXASExact Sciences says Meriter-UnityPoint Health to offer Cologuard
Subscribe for More Information
October 28, 2014
10:12 EDTEXASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:26 EDTEXASExact Sciences downgraded to Equal Weight from Overweight at Stephens
Stephens downgraded Exact Sciences to Equal Weight due to valuation.
October 27, 2014
07:31 EDTEXASExact Sciences reports Q3 EPS (39c), consensus (32c)
Subscribe for More Information
October 22, 2014
08:05 EDTEXASMDVIP announces Cologuard to be availble by perscription
Subscribe for More Information
October 21, 2014
10:53 EDTEXASExact Sciences, Lumber Liquidators shorts recomended by Tilson, Bloomberg says
Kase Capital's Whitney Tilson recommended short positions in Exact Sciences (EXAS) and Lumber Liquidators (LL) while speaking at the Robin Hood Conference, according to Bloomberg.
October 16, 2014
11:21 EDTEXASOptions with decreasing implied volatility: EXAS ATLS LOCO MAT
Subscribe for More Information
07:02 EDTEXASExact Sciences CEO Conroy to be interviewed
CEO Conroy discusses the development of Cologuard, the first and only FDA approved, noninvasive stool DNA screening test for colorectal cancer in an interview on The Traders Network to be held on October 16 at 7:30 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use